Covid-19 Rules and other directives

…The India health ministry updated its guidelines on April 28 for quarantines, treating the asymptomatic and those with mild symptoms of COVID-19. The agency now says that asymptomatic patients should “consider Tab Ivermectin (200 mcg/kg once a day, to be taken empty stomach) for 3 to 5 days.” Caregivers of patients in quarantine are instructed to “take Hydroxychloroquine prophylaxis as per protocol and as prescribed by the treating medical officer.” See the full document here.

There are 292 studies (219 are peer-reviewed) proving the effectiveness of hydroxychloroquine as both a treatment and prophylaxis against COVID-19. Ivermectin has 93 studies (54 peer-reviewed) showing its effectiveness as treatment and prophylaxis against COVID-19. Despite the now-indisputable fact that these drugs essentially kill COVID-19 within hours or days, the Bill Gates-funded World Health Organization (WHO) and big pharma are having fits over India’s new guidelines and the results.

And now the COVID cases are plummeting.

There are currently 311 studies, including 229 peer-reviewed studies (as of June 22, 2021) showing that hydroxychloroquine is highly effective for treating both early and late stage COVID patients. It is also effective as a prophylaxis. The drug is very cheap to manufacture.

There are currently at least 126 studies, with 82 being peer-reviewed (as of October 28, 2021), showing that Ivermectin is highly effective in treating COVID-19 in early stages, late stages, and as prophylaxis (preventative measure).

Since the start of the SARS-CoV-2 pandemic, both observational and randomized studies have evaluated ivermectin as a treatment for, and as prophylaxis against, COVID-19 infection. A review by the Front Line COVID-19 Critical Care Alliance summarized findings from 27 studies on the effects of ivermectin for the prevention and treatment of COVID-19 infection, concluding that ivermectin “demonstrates a strong signal of therapeutic efficacy” against COVID-19.9 Another recent review found that ivermectin reduced deaths by 75%.10 Despite these findings, the National Institutes of Health in the United States recently stated that “there are insufficient data to recommend either for or against the use of ivermectin for the treatment of COVID-19,”11 and the World Health Organization recommends against its use outside of clinical trials.12